Mycobacteria are the etiologic agents of numerous diseases which account for significant morbidity and mortality in humans and other animal species. Many mycobacteria are intramacrophage pathogens and therefore the macrophage response to infection, which includes synthesis of cytokines such as tumor necrosis factor alpha (TNF-␣) and production of nitric oxide, has important consequences for host immunity. However, very little is known about the macrophage cell signaling pathways initiated upon infection or how pathogenic mycobacteria may modulate the macrophage responses. Using primary murine bone marrow macrophages, we established that p38 and extracellular signal-regulated kinases 1 and 2 of the mitogen-activated protein kinase (MAPK) pathways are activated upon infection with different species of mycobacteria. However, we observed decreased MAPK activity over time in macrophages infected with pathogenic Mycobacterium avium strains relative to infections with nonpathogenic mycobacteria. Furthermore, macrophages infected with M. avium produced lower levels of TNF-␣, interleukin 1, and inducible nitric oxide synthase 2 than macrophages infected with nonpathogenic species. Inhibitor studies indicate that the MAPKs are required for the Mycobacterium-mediated induction of these effector proteins. Our data indicate that MAPKs are activated in macrophages upon invasion by mycobacteria and that this activation is diminished in macrophages infected with pathogenic strains of M. avium, resulting in decreased production of important immune effector proteins. The decreased MAPK activation associated with M. avium infections suggests a novel point of immune intervention by this mycobacterial species.Mycobacterium spp. are intramacrophage pathogens and therefore the engagement of macrophage receptors by mycobacteria is one of the initial steps in the infection process. A macrophage may respond to a mycobacterial infection by secreting cytokines such as tumor necrosis factor alpha (TNF-␣) or interleukin 1 (IL-1) and by producing reactive oxygen and nitrogen intermediates. These effects, among others, are the end result of activating various macrophage-signaling pathways. However, questions remain regarding which pathways are initiated and/or modulated by a mycobacterial infection. Previous studies have shown that mycobacterial components such as lipoarabinomannan (LAM) can stimulate a macrophage response, resulting in the production and secretion of TNF-␣ and IL-1 (1). Studies have also indicated that arabinofuranosyl-terminated LAM isolated from nonpathogenic mycobacteria stimulates a stronger cytokine response in treated macrophages than does mannose-capped LAM (ManLAM) from pathogenic mycobacteria (50, 52). Furthermore, recent work by Ting et al. indicates that human macrophages infected with Mycobacterium tuberculosis are less responsive to gamma interferon, due to a disruption in STAT1 binding to the transcription factor CREB (55). These experiments suggest that mycobacteria and mycobacterial components can modulate...